Pharmacosmos wishes to employ a highly qualified International Sales & Business Manager (ISBM) in the Human Iron Business Unit.
The person will short termed be assisting the Sales and Business Directors in various markets and long termed be responsible for Pharmacosmos sales and business development for Pharmacosmos human iron products and shall work in close cooperation with local business partners to maximise sales of Pharmacosmos’ IV iron portfolio and to establish Monofer® leadership in each of the therapeutic areas of the parenteral human iron market.
The ISBM is responsible for sales and business development in the assigned markets and regions. The sales responsibility entails all commercial activities needed to support partners and management of partners to maximise sales results. Business Development include all activities related to partner selection, change of partnerships and manage the cross departmental process until registration and successful commercialisation of brands/products.
The position is based at Pharmacosmos HQ in Holbæk.
You will report to the Head of International Sales & Business, Human Iron and be responsible for:
The ISBM at Pharmacosmos has professional qualifications from the Pharmaceutical industry within Sales, Marketing and Business Management, local/regional experience, strength to lead processes, establish best in class collaboration with local partners and is to cooperate closely with HQ departments such as Marketing, Medical Affairs, Clinical and Regulatory Affairs.
Experienced in MS Office
Up to 60 days per year
This position reports to the Head of International Sales & Business., Lars Ploug Hansen.
CV and application should be in English.
The job is located in Holbæk, Sjælland.
If you have any questions or want to apply for this job, please contact Ole Koch at Nordic Headhunting, e:mail: firstname.lastname@example.org, tel: +45 4020 0855
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt
You are now leaving Pharmacosmos.com. The website you are about to visit is is a Pharmacosmos subsidary. Do you want to proceed?